CN102772536B - 一种治疗肝炎并发肝硬化腹水的中药组合物 - Google Patents
一种治疗肝炎并发肝硬化腹水的中药组合物 Download PDFInfo
- Publication number
- CN102772536B CN102772536B CN2012102840211A CN201210284021A CN102772536B CN 102772536 B CN102772536 B CN 102772536B CN 2012102840211 A CN2012102840211 A CN 2012102840211A CN 201210284021 A CN201210284021 A CN 201210284021A CN 102772536 B CN102772536 B CN 102772536B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- semen phaseoli
- boiling
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010003445 Ascites Diseases 0.000 title claims abstract description 52
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 48
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 41
- 210000000582 semen Anatomy 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 23
- 235000014347 soups Nutrition 0.000 claims abstract description 17
- 241000222640 Polyporus Species 0.000 claims abstract description 11
- 210000003038 endothelium Anatomy 0.000 claims abstract description 11
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 6
- 238000009835 boiling Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 16
- 241000252233 Cyprinus carpio Species 0.000 claims description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 15
- 239000010931 gold Substances 0.000 claims description 15
- 229910052737 gold Inorganic materials 0.000 claims description 15
- 241000252229 Carassius auratus Species 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003826 Artemisia Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 244000183914 Dianthus superbus Species 0.000 abstract 1
- 235000013535 Dianthus superbus Nutrition 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 240000004922 Vigna radiata Species 0.000 abstract 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 abstract 1
- 244000030166 artemisia Species 0.000 abstract 1
- 235000009052 artemisia Nutrition 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 26
- 210000002784 stomach Anatomy 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 19
- 206010030113 Oedema Diseases 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000019425 cirrhosis of liver Diseases 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 11
- 208000019790 abdominal distention Diseases 0.000 description 10
- 230000003187 abdominal effect Effects 0.000 description 10
- 210000001015 abdomen Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000003141 lower extremity Anatomy 0.000 description 9
- 206010016654 Fibrosis Diseases 0.000 description 8
- 206010023126 Jaundice Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000007882 cirrhosis Effects 0.000 description 8
- 230000008034 disappearance Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010008909 Chronic Hepatitis Diseases 0.000 description 7
- 238000009534 blood test Methods 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010016766 flatulence Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010017577 Gait disturbance Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010048612 Hydrothorax Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000004064 dysfunction Effects 0.000 description 4
- 230000002124 endocrine Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 238000007449 liver function test Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000002612 cardiopulmonary effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000009527 percussion Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010018045 Gastroptosis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010030124 Oedema peripheral Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000009911 Urinary Calculi Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 238000002575 gastroscopy Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000001809 melena Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010045458 umbilical hernia Diseases 0.000 description 2
- 208000027185 varicose disease Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 210000004258 portal system Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009603 uroscopy Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗肝炎并发肝硬化腹水的中药组合物,其特征在于:先按以下重量百分比称取各中药原料:鲫鱼35-45%、赤小豆35-45%、柴胡0.9-1.5%、黄芩0.8-1.4%、栀子0.8-1.4%、茵陈蒿1.3-1.8%、黄柏0.9-1.4%、瞿麦1.0-3.0%、绿豆皮0.8-2.0%、白术0.9-1.4%、猪苓1.3-2.0%、当归1.3-1.8%、青皮1.3-1.8%、白芍1.3-1.8%、鸡内金1.0-1.4%、枳实1.3-1.8%、甘草0.1-0.5%;再制鲫鱼汤和赤小豆水;最后与其他药物煎煮滤出。该中药组合物,不仅无毒副作用,且治疗效果好、治疗费用低、患者均容易接受和采纳。
Description
技术领域
本发明涉及中药制剂领域,具体地说是一种治疗肝炎并发肝硬化腹水的中药组合物。
背景技术
肝炎并发肝硬化腹水是一种严重危害人类健康的常见病,是肝炎病的并发症,据有关资料报道,我国肝病患者约有3000万,其中有三分之一转化为肝炎并发肝硬化腹水,因此,研究能够治愈肝炎并发肝硬化腹水病症是一个重大课题。肝炎并发肝硬化腹水是肝病的失代偿期,其临床症状主要包括:门静脉高压症、脾脏肿大、腹水、肝功能减退。腹水的出现标志着肝细胞机能和门静脉系代偿机能的减退,大量腹水时全腹膨隆、腹壁紧张发亮,甚至引起脐疝和下肢浮肿;由于膈肌升高,引起心悸、气短,不能平卧、影响进食。临床中,还有辅助检查:包括血液检查、尿检查、肝功能检查、腹水检查、X线钡餐或胃镜检查、B超检查。超声诊断失代偿肝硬化具有较大的优势,比较容易诊断。根据以上检查,对于肝炎并发肝硬化腹水的病症可准确的诊断。目前对肝炎并发肝硬化肝腹水的治疗,西医一般根据检查指标采用滴注保肝脱水的对症药物治疗,对于轻型早期患者,症状能够缓解,但不能治愈,过后仍然反复发作;对于重型、晚期患者,大都症状缓解不彻底,而且检验费、药费、治疗费都很高,毒副作用大。中医治疗肝炎并发肝硬化腹水的中药较多,但大都是采用活血化瘀、利水机理配方施治,症状大都能够缓解,但治愈率极低,复发率高。经过检索,目前尚未发现能够确切治愈肝炎并发肝硬化腹水的固定方剂。
发明内容
本发明的目的在于提供一种既能缓解肝炎并发肝硬化腹水的症状,又能提高肝硬化腹水的治愈率,治疗时间短、且无毒副作用的一种治疗肝炎并发肝硬化腹水的中药组合物。
为了达到以上目的,本发明所采用的技术方案是:该一种治疗肝炎并发肝硬化腹水的中药组合物,其特征在于:
(1)按以下重量百分比称取各中药原料:鲫鱼35-45%、赤小豆35-45%、柴胡0.9-1.5%、黄芩0.8-1.4%、栀子0.8-1.4%、茵陈蒿1.3-1.8%、黄柏0.9-1.4%、瞿麦1.0-3.0%、绿豆皮0.8-2.0%、白术0.9-1.4%、猪苓1.3-2.0%、当归1.3-1.8%、青皮1.3-1.8%、白芍1.3-1.8%、鸡内金1.0-1.4%、枳实1.3-1.8%、甘草0.1-0.5%;
(2)、其制备方法为:制取鲫鱼汤和赤小豆水:将鲫鱼放入一个锅内,加水1000毫升,武火至开锅,文火煎煮1-2个小时,过滤后,即制得鲫鱼汤;与此同时,将赤小豆放入另一个锅内,加水1000毫升,浸泡1-2个小时,武火至开锅,文火煎煮1-2个小时,过滤后,即制得赤小豆水;
将制取的鲫鱼汤和赤小豆水混合液的一半倒入砂锅内,将柴胡、黄芩、栀子、茵陈蒿、黄柏、瞿麦、绿豆皮、白术、猪苓、当归、青皮、白芍、鸡内金、枳实和甘草药物同时放入砂锅内,在鲫鱼汤和赤小豆水混合液内浸泡1-2个小时,武火至开锅,文火煎煮25-35分钟,滤出药液,药渣留在砂锅内,制得第一次制剂;再将制取的鲫鱼汤和赤小豆水混合液的另一半倒入盛有药渣的砂锅内,武火至开锅,文火煎煮25-35分钟,滤出药液,制得第二次制剂;将第一次制剂和第二次制剂混合,即为治疗肝炎并发肝硬化腹水的中药组合物,装入瓶内备用,每瓶盛750毫升。
本发明的服用方法:饭前口服,一日三次,每次服250毫升;先服15天,当临床症状减轻时,继续服用,30天为一疗程。
临床应用资料分析:
一、资料来源
2001年1 月至2008年1月,在莱芜市中医医院临床应用,共有60例肝炎并发肝硬化肝腹水患者应用本发明治疗,其中男性36例,女性24例,年龄在22-68岁之间。
二、肝炎并发硬化肝腹水的诊断标准
有慢性肝炎肝硬化病史,腹水前常有腹胀,大量水使腹部膨隆、腹壁绷紧发高亮,状如蛙腹,腰围增大、体重增长、下肢浮肿,患者行走困难,有时膈显著抬高,出现呼吸和脐疝;有的患者伴有胸水,出现门静脉压力升高、白蛋白降低、肾脏有效循环血量减少、内分泌功能紊乱等;同时增加常规辅助检查,辅助检查结果符合肝炎并发硬化肝腹水病症指标。
三、疗效标准
治愈:服用本发明治疗,服用15天,临床症状减轻,再服用30天,临床症状消失,再服用一个疗程维持,随访3年,未见复发。
有效:服本发明治疗,服用15天,临床症状减轻,再服用30天,临床症状明显减轻,再服用一个疗程,临床症状消失,随访3年,3年内有复发现象。
无效:服用本发明治疗,服15天,临床症状无减轻。
四、疗效分析
对以上确诊的60例肝炎并发肝硬化肝腹水病人,均住院治疗,住院前均在镇医院或其他医院采用西药治疗过,住院后服用本发明治疗,服用15天后,有59例临床症状均有明显减轻,有效率为98.3%;再服用30天后,有58例临床症状消失,3年内未复发者有57例,治愈率为95.0%;有1例在3年内复发,后又继续服用本发明治疗;有1例服用15天后,临床症状无减轻,转入省医院治疗,无效率为1.7%。应用证明:服用本发明治疗肝炎并发肝硬化腹水病人,治疗效果明显提高。
药理分析
鲫鱼:味甘,平。归脾、胃、大肠经。功用主治:健脾和胃,利水消肿,通血脉。主治脾胃虚弱,纳少反胃,产后乳汁不行,痢疾,便血,水肿,痈肿,肝肾疾病,心脑血管疾病,如肝炎、肾炎、高血压、心脏病,慢性支气管炎等证。
赤小豆:甘,酸,微寒。归心、小肠、脾经。功用主治:利水消肿退黄,清热解毒消痈,行血止痢。主治水肿,脚气,黄疸,淋病,便血,肿毒疮疡,癣疹。
柴胡:苦、辛,微寒。归肝、胆经。功用主治:解表退热,疏肝解郁,升举阳气。主治外感发热,寒热往来,疟疾,肝郁胁痛乳胀,头痛头眩,月经不调,气虚下陷之脱肛、子宫脱垂、胃下垂。
黄芩:苦,寒。归肺、心、肝、胆、大肠经。功用主治:清热泻火,燥湿解毒,止血,安胎。主治肺热咳嗽,热病高热神昏,肝火头痛,目赤肿痛,湿热黄疸,泻痢,热淋,吐衄,崩漏,胎热不安,臃肿疔疮。
栀子:苦,寒。归心、肺、肝、胃、三焦经。功用主治:泻火除烦,清热利湿,凉血解毒。主治热病心烦,肝火目赤,头痛,湿热黄胆,淋症,吐血,血痢,尿血,口舌生疮,疮疡肿毒,扭伤肿痛。
茵陈蒿:微苦、微辛,微寒。归脾、胃、膀胱经。功用主治:清热利湿,退黄,散热解表。主治黄疸,小便不利,湿疮瘙痒,亦可与溫热药配伍用于寒湿发黄之证,暑疫湿溫初起,湿热郁于表分,寒热头痛等证。
黄柏:苦,寒。归肾、膀胱、大肠经。功用主治:清热燥湿,泻火解毒。主治湿热痢疾、泄泻、黄疸,梦遗、淋浊、带下,发热怕冷,恶心呕吐,腹胀,骨蒸劳热,痿躄,以及口舌生疮,目赤肿痛,痈疽疮毒,皮肤湿疹。
瞿麦:苦,寒。归心、肝、小肠、膀胱经。功用主治:利小便,清湿热,活血通经。主治小便不通,热淋,血淋,石淋,闭经,目赤肿痛,痈肿疮毒,湿疮瘙痒。
绿豆皮:甘,寒。归心、胃经。功用主治:消暑止渴,利尿解毒,利水之功效。主治暑热烦渴,水肿,泄泻,痢疾,痈肿,丹毒,解热药毒等证。
白术:甘、苦,溫。归脾、胃经。功用主治:健脾益气,燥湿利水,止汗安胎。主治脾虛湿滞,大便泄泻,体倦食少腹胀,泄泻,便秘,小便不利,水肿,脾胃功能衰弱,消化不良,不思饮食,身面浮肿,暑热烦渴,丹毒,痈肿,解热药毒等证。
猪苓:甘、淡,平。归脾、肾、膀胱经。功用主治:利水渗湿。主治小便不利,水肿胀满,泄泻,带下,脚气浮肿。
当归:甘辛、苦,温。归肝、心、脾经。具有补血活血,调经止痛,润燥滑肠的功效。主治血虚诸证,月经不调,闭经,痛经,崩漏,虚寒腹痛,肠燥便难,跌扑损伤。本药甘温质润,为补血活血之圣药。能润肠通便。当归含有挥发油,能拟制子宫平滑肌收缩或兴奋,并能促进血红蛋白及红细泡的生成,改善血液循环,促进肝细跑再生。
青皮:甘、辛,溫。归肝、胆、胃经。功用主治:疏肝破气,消积化滞。主治胁肋、乳房、胃脘胀痛,乳核,乳痈,疝气,食积,消化不良,食欲不振,呕噯吞酸等证。
白芍:苦、酸,微寒。归肝、脾经。功用主治:养血和营,缓急止痛,敛阴平肝。主治血虚寒热,腕腹疼痛,胁痛,肢体痉挛疼痛,痛经,月经不调,崩漏,自汗,盗汗,下痢泄泻,头痛眩晕。
鸡内金:甘、涩,平。归脾、胃、膀胱经。功用主治:健脾胃,消食积,化石。主治食积,泄泻,胆石症,沙淋,石淋,结石,腹胀,饮食少思,脾虛腹泻,日久难愈。
枳实:苦,辛,微寒。归脾、胃、大肠经。功用主治:破气消积,泻痰除痞。主治积滞内停,痞满胀痛,大便秘结,泻痢后重,结胸,胸痹,胃下垂,子宫脱垂,脱肛。
甘草:甘,平。归脾、胃、心、肺经。功用主治:和中缓急,润肺,解毒,调和诸药。炙用治脾胃虚弱,倦怠食少,腹痛便溏,四肢挛急疼痛,心悸,脏躁,肺痿咳嗽;生用治咽喉肿痛,痈疮肿毒,小儿胎毒,及药物、食物中毒。
本发明以鲫鱼、赤小豆、柴胡、黄芩、栀子、茵陈蒿、黄柏为君药,特别对鲫鱼、赤小豆采用了无毒超量的配比和单煎的方法,主利尿、导湿、补气、提高免疫力于一体;以瞿麦、绿豆皮、白术、猪苓为臣药,佐以当归、青皮、白芍、鸡内金、枳实。甘草协调。诸药相配共奏肝炎并发肝硬化肝腹水的治疗,取得了明显效果。
本发明的有益效果在于:与目前治疗肝炎并发肝硬化腹水病症采用的中药相比,不仅无毒副作用,而且明显的提高了治疗效果、治疗费用低、患者及其家属均容易接受和采纳。
具体实施方式
实施例1
该治疗肝炎并发肝硬化腹水的中药组合物,它由以下重量百分比的中药原料和配制方法制成:先按服用三天的量配制:
(1)按以下重量百分比称取各中药原料:鲫鱼40%、赤小豆40%、柴胡1.2%、黄芩1.1%、栀子1.1%、茵陈蒿1.5%、黄柏1.2%、瞿麦2.0%、绿豆皮1.4%、白术1.1%、猪苓1.6%、当归1.5%、青皮1.6%、白芍1.6%、鸡内金1.2%、枳实1.6%、甘草0.3%;
(2)、其制备方法为:制取鲫鱼汤和赤小豆水:将鲫鱼放入一个锅内,加水1000毫升,武火至开锅,文火煎煮1-2个小时,过滤后,即制得鲫鱼汤;与此同时,将赤小豆放入另一个锅内,加水1000毫升,浸泡1-2个小时,武火至开锅,文火煎煮1.5个小时,过滤后,即制得赤小豆水;
将制取的鲫鱼汤和赤小豆水混合液的一半倒入砂锅内,将柴胡、黄芩、栀子、茵陈蒿、黄柏、瞿麦、绿豆皮、白术、猪苓、当归、青皮、白芍、鸡内金、枳实和甘草药物同时放入砂锅内,在鲫鱼汤和赤小豆水混合液内浸泡1.5个小时,武火至开锅,文火煎煮30分钟,滤出药液,药渣留在砂锅内,制得第一次制剂;再将制取的鲫鱼汤和赤小豆水混合液的另一半倒入盛有药渣的砂锅内,武火至开锅,文火煎煮30分钟,滤出药液,制得第二次制剂;将第一次制剂和第二次制剂混合,即制得治疗肝炎并发肝硬化腹水的中药组合物,装入瓶内备用,每瓶盛750毫升。
服用方法:饭前口服,一日三次,每次服250毫升;先服15天,当临床症状减轻时,继续服用,30天为一疗程。
采用本配比,共治疗20例肝炎并发肝硬化肝腹水病人,这20例的症状均为:有慢性肝炎肝硬化病史,腹水前常有腹胀,大量水使腹部膨隆、腹壁绷紧发高亮,状如蛙腹,腰围增大、体重增长、下肢浮肿,患者行走困难,有时膈显著抬高,出现呼吸和脐疝。部分患者伴有胸水,出现门静脉压力升高、白蛋白降低、肾脏有效循环血量减少、内分泌功能紊乱等。并通过辅助检查,确诊为肝炎并发肝硬化腹水。治疗方法,入院后,给予服本发明治疗,服30天,临床症状消失,出院后每月复查一次,3年内未复发,视为全部治愈。
典型病例:姜然,女,32岁,山东省莱芜市莱城区杨庄镇人。于2003 年9月1 3日来莱芜市中医医院就诊,门诊以肝炎并发肝硬化腹水收住院治疗。患者素有慢性肝炎并发肝硬化腹水病史5年,反复发作,时发时愈,近10天来,出现食欲减退、恶心、腹胀、腹泻黑便、踝部浮肿等全身症状,逐渐加重。入院查体:T37.1℃,一般情况可,心肺(-), 腹部膨隆、腹壁绷紧发高亮,状如蛙腹,腹部叩诊,有移动性浊音,下肢浮肿,患者行走困难。辅助检查:血液检查:血常规:白细胞3.5 X 109、中性细胞比率65%、淋巴细胞比率23%、单核细胞比率2%;尿胆红质试验阳性;肝功能试验:血清谷丙转氨酶多数正常;腹水检查:属漏出液;X线钡餐检查:可发现食管下段静脉或胃底静脉曲张;B超检查:腹腔见液平反射。入院确诊为肝炎并发肝硬化腹水。在镇医院曾给予常规西药输液治疗。服用本发明治疗,饭前口服,每日三次,每次250ml。服用15天后,临床症状明显减轻,再服用30天后,临床症状消失,痊愈出院。3年内随访未复发。
实施例2
配制方法和服用方法同实施例1。其中在(1)步骤中,按以下重量百分比称取各中药原料:鲫鱼35%、赤小豆45%、柴胡0.9%、黄芩1.4%、栀子0.8%、茵陈蒿1.7%、黄柏0.9%、瞿麦3.0%、绿豆皮0.8%、白术1.4%、猪苓1.3%、当归1.8%、青皮1.3%、白芍1.8%、鸡内金1.0%、枳实1.8%、甘草0.1%。
采用本配比,共治疗20例肝炎并发肝硬化肝腹水病人,这20例的症状均为:有慢性肝炎肝硬化病史,有腹胀,腹部膨隆、腹壁绷紧发高亮,状如蛙腹,腰围增大、体重增长、下肢浮肿,患者行走困难,有时膈显著抬高,出现呼吸,部分患者伴有胸水,出现门静脉压力升高、白蛋白降低、肾脏有效循环血量减少、内分泌功能紊乱等,入院前在镇医院或其他医院治疗过。通过检查,确诊为肝炎并发肝硬化腹水。治疗方法,入院后,服用本发明一个疗程临床症状消失,随访3年,未见复。
典型病例:李伟华,男,39岁,山东省莱芜市莱城区口镇东街村。于2004 年6月1 9日来莱芜市中医医院就诊,门诊以肝炎并发肝硬化腹水收住院治疗。患者素有慢性肝炎并发肝硬化腹水病史6年,反复发作,时发时愈,近15天来,出现纳差、恶心、腹胀、下肢浮肿等。自诉曾在多家医院西药治疗,近来逐渐加重 。入院查体:T36.9℃,一般情况可,心肺(-), 腹部膨隆、腹壁绷紧发高亮,状如蛙腹,腹部叩诊,有移动性浊音,下肢浮肿。辅助检查中,血液检查:血常规:白细胞3.6 X 109、中性细胞比率63%、淋巴细胞比率24%、单核细胞比率3%;肝功能试验: 血清谷丙转氨酶多数正常;腹水检查:属漏出液;胃镜检查:发现食管下段静脉或胃底静脉曲张;B超检查:腹腔见液平反射。入院确诊为肝炎并发肝硬化腹水。服本发明治疗,饭前口服,每日三次,每次250ml。服用15天后,临床症状明显减轻,再服用30天后,临床症状消失,痊愈出院。3年内随访未复发。
实施例3
配制方法和服用方法同实施例1。其中在(1)步骤中,按以下重量百分比称取各中药原料:鲫鱼45%、赤小豆35%、柴胡1.5%、黄芩0.8%、栀子1.4%、茵陈蒿1.3%、黄柏1.4%、瞿麦1.1%、绿豆皮2.0%、白术0.9%、猪苓2.0%、当归1.3%、青皮1.8%、白芍1.3%、鸡内金1.4%、枳实1.3%、甘草0.5%
采用本配比,共治疗20例肝炎并发肝硬化肝腹水病人,这20例的症状均为:有慢性肝炎肝硬化病史,食欲减退、恶心、腹胀、浮肿等全身症状,逐渐加重。查体:腹部膨隆、状如蛙腹,下肢浮肿。有时出现呼吸困难,部分患者伴有胸水,出现门静脉压力升高、白蛋白降低、肾脏有效循环血量减少、内分泌功能紊乱等。通过检查,确诊为肝炎并发肝硬化腹水。治疗方法,入院后,口服本发明治疗,服15天后,有一例无效,转院治疗,有一例虽然治好,但2年零一个月时又复发,又进行口服本发明治疗;其余的均为治愈。
典型病例:张伟,男,56岁,住莱芜市莱城区泰钢集团宿舍。于2001 年9月2 3日来莱芜市中医医院就诊,门诊以肝炎并发肝硬化腹水住院治疗。患者诉有慢性肝炎并发肝硬化腹水病史8年,曾多家医院西药治疗,但反复发作,时发时愈,近10天来,出现食欲减退、恶心、腹胀、腹泻黑便、踝部浮肿等全身症状。逐渐加重 。入院查体:T37.1℃;心肺(-); 腹部膨隆、腹壁绷紧发高亮,状如蛙腹,腹部叩诊,有移动性浊音,下肢浮肿,患者行走困难。辅助检查:血液检查:血常规:白细胞4.1 X 109、中性细胞比率68%、淋巴细胞比率21%、单核细胞比率1%;肝功能试验:血清谷丙转氨酶多数正常;腹水检查:属漏出液;B超检查,腹腔见液平反射;入院确诊为肝炎并发肝硬化腹水。服本发明治疗,饭前口服,每日服三次,每次250ml。服用15天后,临床症状明显减轻,再服用30天后,临床症状消失,痊愈出院,3年内随访未复发。
Claims (1)
1.一种治疗肝炎并发肝硬化腹水的中药组合物,其特征在于:
(1)按以下重量百分比称取各中药原料:鲫鱼35-45%、赤小豆35-45%、柴胡0.9-1.5%、黄芩0.8-1.4%、栀子0.8-1.4%、茵陈蒿1.3-1.8%、黄柏0.9-1.4%、瞿麦1.0-3.0%、绿豆皮0.8-2.0%、白术0.9-1.4%、猪苓1.3-2.0%、当归1.3-1.8%、青皮1.3-1.8%、白芍1.3-1.8%、鸡内金1.0-1.4%、枳实1.3-1.8%、甘草0.1-0.5%;
(2)、其制备方法为:制取鲫鱼汤和赤小豆水:将鲫鱼放入一个锅内,加水1000毫升,武火至开锅,文火煎煮1-2个小时,过滤后,即制得鲫鱼汤;与此同时,将赤小豆放入另一个锅内,加水1000毫升,浸泡1-2个小时,武火至开锅,文火煎煮1-2个小时,过滤后,即制得赤小豆水;
将制取的鲫鱼汤和赤小豆水混合液的一半倒入砂锅内,将柴胡、黄芩、栀子、茵陈蒿、黄柏、瞿麦、绿豆皮、白术、猪苓、当归、青皮、白芍、鸡内金、枳实和甘草药物同时放入砂锅内,在鲫鱼汤和赤小豆水混合液内浸泡1-2个小时,武火至开锅,文火煎煮25-35分钟,滤出药液,药渣留在砂锅内,制得第一次制剂;再将制取的鲫鱼汤和赤小豆水混合液的另一半倒入盛有药渣的砂锅内,武火至开锅,文火煎煮25-35分钟,滤出药液,制得第二次制剂;将第一次制剂和第二次制剂混合,即制得治疗肝炎并发肝硬化腹水的中药组合物,装入瓶内备用,每瓶盛750毫升。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102840211A CN102772536B (zh) | 2012-08-11 | 2012-08-11 | 一种治疗肝炎并发肝硬化腹水的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102840211A CN102772536B (zh) | 2012-08-11 | 2012-08-11 | 一种治疗肝炎并发肝硬化腹水的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102772536A CN102772536A (zh) | 2012-11-14 |
| CN102772536B true CN102772536B (zh) | 2013-10-30 |
Family
ID=47117793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102840211A Expired - Fee Related CN102772536B (zh) | 2012-08-11 | 2012-08-11 | 一种治疗肝炎并发肝硬化腹水的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102772536B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104544358B (zh) * | 2015-01-13 | 2018-03-30 | 李国强 | 海参保健汤及其制备方法 |
| CN106620588A (zh) * | 2016-04-13 | 2017-05-10 | 张家新 | 一种肝炎并发肝硬化腹水的中药制剂及其制备方法和应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907462A (zh) * | 2006-08-07 | 2007-02-07 | 张庆存 | 一种治疗肝炎和脂肪肝的中药组合物 |
-
2012
- 2012-08-11 CN CN2012102840211A patent/CN102772536B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907462A (zh) * | 2006-08-07 | 2007-02-07 | 张庆存 | 一种治疗肝炎和脂肪肝的中药组合物 |
Non-Patent Citations (2)
| Title |
|---|
| 中国中西医结合学会消化系统疾病专业委员会.肝硬化中西医结合诊治方案.《现代消化及介入诊疗》.2005,第10卷(第2期),119-121. |
| 肝硬化中西医结合诊治方案;中国中西医结合学会消化系统疾病专业委员会;《现代消化及介入诊疗》;20050228;第10卷(第2期);119-121 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102772536A (zh) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071023B (zh) | 一种有效治疗消渴症的中药组合物 | |
| CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
| CN104225486A (zh) | 一种治疗慢性胆囊炎的中药 | |
| CN102488875B (zh) | 治疗继发性痛经的中药 | |
| CN101607067B (zh) | 一种治疗胆结石的中药制剂及制备方法 | |
| CN102772536B (zh) | 一种治疗肝炎并发肝硬化腹水的中药组合物 | |
| CN101569738A (zh) | 一种治疗乳腺炎、乳腺增生、乳房肿块、关节积液、跌打损伤的膏药及其制备方法与应用 | |
| CN104107398A (zh) | 一种治疗风湿性心脏病的中药组合物 | |
| CN103272189B (zh) | 一种治疗胆结石的药物 | |
| CN102274445A (zh) | 桂枝三棱消瘤丸 | |
| CN102872362B (zh) | 一种治疗慢性胆囊炎的中药 | |
| CN104189508A (zh) | 治疗甲状腺肿大的中药 | |
| CN103623346A (zh) | 治疗腹部手术后腹胀的中药 | |
| CN104721745A (zh) | 一种治疗慢性胰腺炎的中药组合物 | |
| CN104352803A (zh) | 一种治疗胃癌的中药制剂 | |
| CN104491316B (zh) | 一种治疗中气不足型前列腺增生症的中药制剂 | |
| CN103520638B (zh) | 一种治疗前列腺肥大症的中药复方组合物及其制备方法及其应用 | |
| CN101869629B (zh) | 一种治疗肾结石的中药 | |
| CN102626498B (zh) | 治疗慢性胰腺炎的前苓赤金汤 | |
| CN101019966B (zh) | 一种补脑养肢壮阳酒及其制备方法 | |
| CN104352950A (zh) | 一种治疗妇科炎症的中药组合物 | |
| CN105999060A (zh) | 一种治疗妇女血瘀型癥瘕的中药组合物及其制备方法 | |
| CN105456954A (zh) | 一种治疗痤疮的中药组合物及其制剂 | |
| CN104306943A (zh) | 一种治疗高血脂症的中药组合物 | |
| CN104352963A (zh) | 一种治疗慢性盆腔炎的中药制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131030 Termination date: 20140811 |
|
| EXPY | Termination of patent right or utility model |